Sign in Create account Request Demo

States / U.S. Congress / HR 679

HR 679 In Committee

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Overview Bill text 1 History 2 Sponsors
Introduced in House Jan 23, 2025 · 353 words Open full page ↗

I

119TH CONGRESS

1ST SESSION

H. R. 679

To nullify the modifications made by the Food and Drug Administration

in January 2023 to the risk evaluation and mitigation strategy for

the abortion pill mifepristone, and for other purposes.

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in